MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY IN CHROMOSOME-9AND CHROMOSOME-16 IN HUMAN BREAST EPITHELIAL-CELLS TRANSFORMED BY CHEMICAL-CARCINOGENS
Yl. Wu et al., MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY IN CHROMOSOME-9AND CHROMOSOME-16 IN HUMAN BREAST EPITHELIAL-CELLS TRANSFORMED BY CHEMICAL-CARCINOGENS, Carcinogenesis, 18(5), 1997, pp. 1069-1074
Microsatellite instability (MSI) and loss of heterozygosity (LOH) in c
hromosomes 9 and 16 have been reported in human breast cancers. In ord
er to determine whether changes in these chromosomes play a role in th
e initiation and progression of this disease, we performed microsatell
ite polymorphism analyses in human breast epithelial cells (HBEC) tran
sformed by chemical carcinogens, an in vitro system that recapitulates
various stages of neoplastic transformation, In this experimental sys
tem we studied the mortal HBEC MCF-10M, immortal MCF-10F cells, derive
d from MCF-10M cells, and clones derived from MCF-10F cells treated wi
th benzo[a]pyrene (B[a]P) (BP1 and BP1E) and 7,12-dimethylbenz[a]anthr
acene (DMBA) (D3 and D3-1). The four clones of transformed cells were
injected into severe combined immunodeficient (SCID) mice. Only BP1-E
cells induced the formation of tumors, designated BP1E-Tp cells. These
cells originated six additional tumors, designated BP1E-Tf no. 1 thro
ugh Tf no. 6. Microsatellite analyses were carried out using five mark
ers for chromosome 9 and 20 for chromosome 16. There was no evidence o
f MSI or LOH in clones BP1 and BP1E when compared with the MCF-10M and
MCF-10F cells, whereas BP1E-Tp cells and Bp1E-Tf no. 1-Tf no. 6 tumor
s exhibited MSI at loci p23 and p21, and LOH at p21-22 of chromosome 9
. They also exhibited MSI and LOH at multiple loci of both the short a
nd long arms of chromosome 16, i.e. p13.13, p13.3, p12, q12.1, q12.2,
q23 and q24, to which putative tumor suppressor genes have been locali
zed. Clones D3 and D3-1 exhibited no genomic changes in chromosome 9,
but did show MSI at locus q12.1 of chromosome 16 using marker D16S285,
Although the cells treated with DMBA expressed early phenotypes of ne
oplastic transformation, they were not tumorigenic, and also manifeste
d fewer changes than the tumorigenic BP1E-Tp cells and the tumors BP1E
-Tf. The changes in chromosomes 9 and 16 observed in these latter ones
indicated an association with the expression of tumorigenesis, which
represents a late event in the progression of the neoplastic transform
ation of HBEC. Of interest was the observation that HBEC transformed b
y chemical carcinogens in vitro express genomic changes similar to tho
se found in spontaneous breast carcinomas.